Just a moment, the page is loading...
Notice to Investigators involved in Pure Substance Request studies: Due to temporary supply issues, there may be a delay in the processing or shipping of pure substances at this time. We apologize for the inconvenience, and we appreciate your understanding.
♥




Advancing Evidence in Cabotegravir for HIV Prevention (General)

ViiV Healthcare welcomes investigator-sponsored research that advances understanding of cabotegravir in HIV prevention across a wide range of scientific priorities. Research of interest may include real-world effectiveness, safety and tolerability, patient and provider experience, quality of life, healthcare resource use, economic value, and health equity. We encourage innovative approaches and studies in diverse populations that can expand real-world knowledge and inform clinical practice.






ViiV ISR Area Of Interest Overview

Drug/Product Alignment
Cabotegravir
Long Acting - PreP
Area of Interest/DataGap Description
Open
All scientifically sound and relevant research questions related to this area will be considered.
Desirable Study Parameters
All Patient Types
Global

Version 20250909-disp



- Back to Top -
© 2026 ViiV Healthcare
Trademarks are owned by or licensed to the ViiV Healthcare group of companies